These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32800099)

  • 21. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
    Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial.
    Atkin W; Wooldrage K; Parkin DM; Kralj-Hans I; MacRae E; Shah U; Duffy S; Cross AJ
    Lancet; 2017 Apr; 389(10076):1299-1311. PubMed ID: 28236467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.
    Johns LE; Coleman DA; Swerdlow AJ; Moss SM
    Br J Cancer; 2017 Jan; 116(2):246-252. PubMed ID: 27931047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
    Jacobs IJ; Menon U; Ryan A; Gentry-Maharaj A; Burnell M; Kalsi JK; Amso NN; Apostolidou S; Benjamin E; Cruickshank D; Crump DN; Davies SK; Dawnay A; Dobbs S; Fletcher G; Ford J; Godfrey K; Gunu R; Habib M; Hallett R; Herod J; Jenkins H; Karpinskyj C; Leeson S; Lewis SJ; Liston WR; Lopes A; Mould T; Murdoch J; Oram D; Rabideau DJ; Reynolds K; Scott I; Seif MW; Sharma A; Singh N; Taylor J; Warburton F; Widschwendter M; Williamson K; Woolas R; Fallowfield L; McGuire AJ; Campbell S; Parmar M; Skates SJ
    Lancet; 2016 Mar; 387(10022):945-956. PubMed ID: 26707054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of mammographic screening from age 40 ('Age' trial): patterns of screening attendance.
    Johns LE; Moss SM;
    J Med Screen; 2010; 17(1):37-43. PubMed ID: 20356944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
    Moss S
    J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
    Jonsson H; Nyström L; Törnberg S; Lenner P
    J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.
    Tabar L; Yen MF; Vitak B; Chen HH; Smith RA; Duffy SW
    Lancet; 2003 Apr; 361(9367):1405-10. PubMed ID: 12727392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
    Miller AB; Wall C; Baines CJ; Sun P; To T; Narod SA
    BMJ; 2014 Feb; 348():g366. PubMed ID: 24519768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.
    Mittra I; Mishra GA; Dikshit RP; Gupta S; Kulkarni VY; Shaikh HKA; Shastri SS; Hawaldar R; Gupta S; Pramesh CS; Badwe RA
    BMJ; 2021 Feb; 372():n256. PubMed ID: 33627312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
    Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT.
    Bruce J; Mazuquin B; Mistry P; Rees S; Canaway A; Hossain A; Williamson E; Padfield EJ; Lall R; Richmond H; Chowdhury L; Lait C; Petrou S; Booth K; Lamb SE; Vidya R; Thompson AM
    Health Technol Assess; 2022 Feb; 26(15):1-124. PubMed ID: 35220995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.
    Dearnaley D; Hinder V; Hijab A; Horan G; Srihari N; Rich P; Houston JG; Henry AM; Gibbs S; Venkitaraman R; Cruickshank C; Hassan S; Miners A; Mason M; Pedley I; Payne H; Brock S; Wade R; Robinson A; Din O; Lees K; Graham J; Worlding J; Murray J; Parker C; Griffin C; Sohaib A; Hall E;
    Lancet Oncol; 2022 Apr; 23(4):501-513. PubMed ID: 35279270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
    Andersson I; Aspegren K; Janzon L; Landberg T; Lindholm K; Linell F; Ljungberg O; Ranstam J; Sigfússon B
    BMJ; 1988 Oct; 297(6654):943-8. PubMed ID: 3142562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.
    Evans DG; Brentnall AR; Harvie M; Dawe S; Sergeant JC; Stavrinos P; Astley S; Wilson M; Ainsworth J; Cuzick J; Buchan I; Donnelly LS; Howell A
    Cancer Prev Res (Phila); 2014 Oct; 7(10):993-1001. PubMed ID: 25047362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.